help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taniguchi, S.-I.
Right arrow Articles by Kohn, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniguchi, S.-I.
Right arrow Articles by Kohn, L. D.
Molecular Endocrinology 12 (1): 19-33
Copyright © 1998 by The Endocrine Society

Iodide Suppression of Major Histocompatibility Class I Gene Expression in Thyroid Cells Involves Enhancer A and the Transcription Factor NF-{kappa}B

Shin-Ichi Taniguchi1, Minho Shong2, Cesidio Giuliani3, Giorgio Napolitano3, Motoyasu Saji4, Valeria Montani3, Koichi Suzuki, Dinah S. Singer and Leonard D. Kohn

Cell Regulation Section (S.-I.T., M.S., C.G., G.N., M.S., V.M., K.S., L.D.K.) Metabolic Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases and Experimental Immunology Branch (D.S.S.) National Cancer Institute National Institutes of Health Bethesda, Maryland 20892

High concentrations of iodide can induce transient, clinical improvement in patients with autoimmune Graves’ disease. Previous work has related this iodide action to the autoregulatory effect of iodide on the growth and function of the thyroid; more recently, we additionally related this to the ability of iodide to suppress major histocompatibility (MHC) class I RNA levels and antigen expression on thyrocytes. In this report, we describe a transcriptional mechanism involved in iodide suppression of class I gene expression, which is potentially relevant to the autoregulatory action of iodide. Transfection experiments in FRTL-5 cells show that iodide decreases class I promoter activity and that this effect can be ascribed to the ability of iodide to modulate the formation of two specific protein/DNA complexes with enhancer A, -180 to -170 bp, of the class 1 5'-flanking region.1 Thus, iodide decreases the formation of Mod-1, an enhancer A complex involving the p50 subunit of NF-{kappa}B and a c-fos family member, fra-2, which was previously shown to be important in the suppression of class I levels by hydrocortisone. Unlike hydrocortisone, iodide also increases the formation of a complex with enhancer A, which we show, in antibody shift experiments, is a heterodimer of the p50 and p65 subunits of NF-{kappa}B. The changes in these complexes are not duplicated by chloride and are related to the action of iodide on class I RNA levels by the following observations. First, FRTL-5 thyroid cells with an aged phenotype coincidentally lose the ability of iodide to decrease MHC class I RNA levels and to induce changes in either complex. Second, the effect of iodide on class I RNA levels and on enhancer A complex formation with Mod-1 and the p50/p65 heterodimer is inhibited by agents that block the inositol phosphate, Ca++, phospholipase A2, arachidonate signal transduction pathway: acetylsalicylate, indomethacin, and 5,8,11,14-eicosatetraynoic acid. Interestingly, iodide can also decrease formation of the Mod-1 complex and increase formation of the complex with the p50/p65 subunits of NF-{kappa}B when the NF-{kappa}B enhancer sequence from the Ig {kappa} light chain, rather than enhancer A, is used as probe; and both actions mimic the action of a phorbol ester. This suggests that iodide may regulate complex formation with NF-{kappa}B regulatory elements on multiple genes associated with growth and function, providing a potential mechanism relating the autoregulatory action of iodide on thyroid cells and its action on class I gene expression.




This article has been cited by other articles:


Home page
J EndocrinolHome page
C Giuliani, M Saji, I Bucci, G Fiore, M Liberatore, D S Singer, F Monaco, L D Kohn, and G Napolitano
Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells.
J. Endocrinol., June 1, 2006; 189(3): 605 - 615.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Harii, C. J. Lewis, V. Vasko, K. McCall, U. Benavides-Peralta, X. Sun, M. D. Ringel, M. Saji, C. Giuliani, G. Napolitano, et al.
Thyrocytes Express a Functional Toll-Like Receptor 3: Overexpression Can Be Induced by Viral Infection and Reversed by Phenylmethimazole and Is Associated with Hashimoto's Autoimmune Thyroiditis
Mol. Endocrinol., May 1, 2005; 19(5): 1231 - 1250.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. K. Howcroft, J. D. Weissman, A. Gegonne, and D. S. Singer
A T Lymphocyte-Specific Transcription Complex Containing RUNX1 Activates MHC Class I Expression
J. Immunol., February 15, 2005; 174(4): 2106 - 2115.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Napolitano, I. Bucci, C. Giuliani, C. Massafra, C. Di Petta, E. Devangelio, D. S. Singer, F. Monaco, and L. D. Kohn
High Glucose Levels Increase Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells and Amplify Interferon-{gamma} Action
Endocrinology, March 1, 2002; 143(3): 1008 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger
Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models
Endocr. Rev., October 1, 2001; 22(5): 631 - 656.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Napolitano, V. Montani, C. Giuliani, S. Di Vincenzo, I. Bucci, V. Todisco, G. Laglia, A. Coppa, D. S. Singer, M. Nakazato, et al.
Transforming Growth Factor-{beta}1 Down-Regulation of Major Histocompatibility Complex Class I in Thyrocytes: Coordinate Regulation Of Two Separate Elements by Thyroid-Specific as Well as Ubiquitous Transcription Factors
Mol. Endocrinol., April 1, 2000; 14(4): 486 - 505.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Schuppert, D. Ehrenthal, A. Frilling, K. Suzuki, G. Napolitano, and L. D. Kohn
Increased Major Histocompatibility Complex (MHC) Expression in Nontoxic Goiters Is Associated with Iodide Depletion, Enhanced Ability of the Follicular Thyroglobulin to Increase MHC Gene Expression, and Thyroid Autoantibodies
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 858 - 867.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. Kirshner, L. Palmer, J. Bodor, M. Saji, L. D. Kohn, and D. S. Singer
Major Histocompatibility Class I Gene Transcription in Thyrocytes: A Series of Interacting Regulatory DNA Sequence Elements Mediate Thyrotropin/Cyclic Adenosine 3',5'-Monophosphate Repression
Mol. Endocrinol., January 1, 2000; 14(1): 82 - 98.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Kim, T.-H. Lee, E. S. Park, J. M. Suh, S. J. Park, H. K. Chung, O-Y. Kwon, Y. K. Kim, H. K. Ro, and M. Shong
Role of Peroxiredoxins in Regulating Intracellular Hydrogen Peroxide and Hydrogen Peroxide-induced Apoptosis in Thyroid Cells
J. Biol. Chem., June 9, 2000; 275(24): 18266 - 18270.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society